
    
      Ripasudil eye drops will be administrated to all enrolled preterm infants with zone I/II
      stage 1 or greater ROP （except for aggressive posterior ROP, Type1 ROP ）.

      The safety and efficacy of ripasudil in treated patients will be assessed in comparison to a
      historical control.
    
  